Richard Gilbertson awarded Society of Memorial Sloan Kettering Prize
Professor Richard Gilbertson has been named the 2022 recipient of The Society of Memorial Sloan Kettering Prize. The Society Prize is a global recognition that is awarded annually to a researcher, physician, or team lead who has made a positive and lasting impact in the fight against pediatric cancer.
Professor Gilbertson was selected as this year’s recipient for the impact his contributions and discoveries have had on children with cancer. His research into the developmental origins of childhood brain tumors has led not only to an increased understanding of the molecular origins of these tumours, but has also impacted clinical outcomes through risk-stratified treatments and new targeted therapeutic options.
Dr Andrew Kung, Chair of the Department of Pediatrics at MSK Kids said “The Society of Memorial Sloan Kettering Prize recognizes individuals who have made extraordinary contributions to improving outcomes for children with cancer. Prof Gilbertson has made many significant discoveries over the years that have improved the way we as clinicians treat children with brain tumors. We are delighted to honor Prof Gilbertson and I can think of no one more deserving of joining the luminaries who have been honored with this Prize.”
Professor Gilbertson said “It is both exciting and humbling to be honoured with this recognition. I share this award with all my amazing colleagues and collaborators – including countless patients and their families – who together work daily to ensure cancer is no longer a leading cause of death by disease among children across the world.”
Related News
See all news-
World first trial to revolutionise treatment of brain cancer
23rd October 2024
A pioneering research study will trial multiple new treatments for people in the UK living with glioblastoma, an aggressive form of brain cancer.
Find out more -
Institute receives unprecedented £173M commitment from CRUK
15th October 2024
Cancer Research UK has announced a £173 million investment in the Cambridge Institute – the largest single grant ever awarded by the charity outside of London.
Find out more -
Madzia Crossley appointed as Junior Group Leader
1st October 2024
Dr Magdalena (Madzia) Crossley will be joining the Cancer Research UK Cambridge Institute as a Junior Group Leader starting in early 2025.
Find out more